By 2033, the global oral clinical nutrition supplement market is expected to reach USD 19,613.1 million, surpassing USD 10,788.70 million in 2023. The market is expected to record a CAGR of 6.2% indicating positive market growth over the forecast period.
The emphasis on maintaining a good immune system has increased the market for oral clinical nutrition supplements. In the upcoming years, the market for oral clinical nutrition supplements is expected to expand. Due to its uses in addressing malnutrition, it has the potential to help the market for oral clinical nutrition supplements develop substantially. Patients with prolonged illnesses or those who are nutritionally malnourished may benefit from the use of oral clinical nutrition supplements.
Also, patients who find it difficult to eat regular meals because of a loss of taste brought on by a prolonged infection may benefit from taking oral clinical nutrition supplements. There are several oral clinical nutrition supplement manufacturers who are introducing new flavors to attract more consumers. This may remain a key factor in the market’s growth.
Request Your Sample Report Today: https://www.futuremarketinsights.com/reports/sample/rep-gb-9486
The rising demand for health foods, the increasing number of young people, and the growing preference for a range of oral clinical nutrition supplements among the general population are a few of the major factors anticipated to propel the growth of the oral clinical nutrition supplements market.
Key Takeaways from Market Study
- The oral clinical nutrition supplement market is expected to record a CAGR of 6.2% over the forecast period.
- It is estimated that the oral clinical nutrition supplement market in North America may remain strong during the forecast period.
- The launch of oral clinical nutrition formulas in liquid form may continue aiding growth in the form segment with a CAGR of 7.2%
- Flavored oral clinical nutrition supplements are likely to hold a market share of 70%.
- It is expected that the market in the United States may demonstrate a high level of growth by 2033.
- Prescription-based channels are likely to be responsible for more than 90% of sales of oral clinical nutrition supplements.
Competitive Background:
Leading players in the market focus on a variety of market consolidation activities, including mergers, acquisitions, supply distribution partnerships, and product launches. In order to be successful, manufacturers must expand their market footprint and offer solutions to their customers. A variety of end users can now choose from a wide range of customized solutions offered by leading manufacturers.
Several prominent companies dominate this market, including NUTRICIÓN MÉDICA SL, Meiji Holdings Co., Ltd., Medtrition Inc., Baxter International Inc., B. Braun Melsungen AG., Fresenius Kabi AG, Mead Johnson & Company, LLC, Otsuka Holdings Co., Ltd., Abbott Laboratories, Danone Nutricia, Victus, Inc., Cambrooke Therapeutics, Inc., GlaxoSmithKline plc, Nestlé S.A., Kate Farms, Inc., Perrigo Company plc, Sichuan Kelun Pharmaceutical Co., Ltd., AYMES International Ltd., Pfizer Inc., Medifood GmbH, Nature’s Bounty Inc., Pharmavite LLC., and others.
Recent Developments:
- Ensure Harvest and PediaSure Harvest were relaunched in September 2021 with plant-based protein and organic ingredients. As a source of nutrition or as a means of meeting a person’s daily nutritional needs, hence nutritional supplements can be used in many ways.
- Persona, a firm that offers personalized vitamins, has been acquired by Nestlé Health Science in August 2019. The company has the opportunity to expand its personalized nutrition services.
- With only six calories and no caffeine, Matok V’Kal launched a stamina boost-up spray in February 2019.
- With the introduction of PRO-DIP’s new oral clinical nutritional supplement in April 2019, PRO-DIP introduced a revolutionary pouch that provides small, semi-permeable sachets of energy and nutrition.
- In April 2018, Abbott introduced Ensure Max, which is a nutritional drink with high-quality proteins and very low sugar content.
Maximize Growth Potential Grab Your Report Today: https://www.futuremarketinsights.com/checkout/9486
Oral Clinical Nutrition Supplement Market Segmentation by Category
Product Type:
- Standard Formula
- Specialized Formula
Indication:
- General Well-being
- Renal Disorders
- Hepatic Disorders
- Oncology Nutrition
- Diabetes
- Dysphagia
- IBD & GI Tract Disorders
- Neurological Disorders
- Respiratory Orders
- Others
Form:
- Liquid
- Semi-solid
- Powder
End User:
- Adult
- Geriatric
- Pediatric
Flavor:
- Regular
- Flavored
- Chocolate
- Vanilla
- Strawberry
- Apple
- Mixed Berries
- Orange
- Nut Flavours
Channel:
- Prescription-based
- Over-the-Counter
- Modern Trade
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
